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Abstract: We reviewed the associations of immunity-related genes with susceptibility of 
humans and rodents to hantaviruses, and with severity of hantaviral diseases in humans. 
Several class I and class II HLA haplotypes were linked with severe or benign hantavirus 
infections, and these haplotypes varied among localities and hantaviruses. The polymorphism 
of other immunity-related genes including the C4A gene and a high-producing genotype of 
TNF gene associated with severe PUUV infection. Additional genes that may contribute to 
disease or to PUUV infection severity include non-carriage of the interleukin-1 receptor 
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antagonist (IL-1RA) allele 2 and IL-1β (-511) allele 2, polymorphisms of plasminogen  
activator inhibitor (PAI-1) and platelet GP1a. In addition, immunogenetic studies have 
been conducted to identify mechanisms that could be linked with the persistence/clearance 
of hantaviruses in reservoirs. Persistence was associated during experimental infections 
with an upregulation of anti-inflammatory responses. Using natural rodent population  
samples, polymorphisms and/or expression levels of several genes have been analyzed. 
These genes were selected based on the literature of rodent or human/hantavirus interactions 
(some Mhc class II genes, Tnf promoter, and genes encoding the proteins TLR4, TLR7, 
Mx2 and β3 integrin). The comparison of genetic differentiation estimated between bank 
vole populations sampled over Europe, at neutral and candidate genes, has allowed to  
evidence signatures of selection for Tnf, Mx2 and the Drb Mhc class II genes.  
Altogether, these results corroborated the hypothesis of an evolution of tolerance strategies 
in rodents. We finally discuss the importance of these results from the medical and  
epidemiological perspectives. 
Keywords: hantavirus; Puumala virus; interaction; hosts; reservoirs; rodents;  
immunity-related genes 
 
1. Introduction 
1.1. Immunogenetics and Diseases 
It is now well established that host genetic variation influences individual susceptibility to 
infectious as well as autoimmune diseases [1]. The field of immunogenetics is at the core of research 
aiming at identifying and understanding associations between genetic factors and immunological 
phenotypes or immunity-related diseases [2]. Firstly based on candidate gene approaches, 
immunogenetics has now moved towards genomics with the advent of new technologies including 
DNA microarrays and next-generation sequencing. Whole genome sequencing of individuals with 
extreme phenotypes of infectious diseases and subsequent genome-wide association studies are now 
contributing to reveal the genetic bases of human susceptibility to particular infectious diseases and  
to decipher the immunological mechanisms underlying the pathogenesis of these diseases see for  
reviews [1,3,4]. Although similar research has been carried out on infectious diseases of domestic 
animals e.g., [5,6], the application of immunogenetics to wild animals, which constitute a large part of 
the vectors/reservoirs of agents of zoonotic diseases [7], remains scarce. It mainly focused on genes of 
the major histocompatibility complex (Mhc, equivalent of Hla—human leukocyte antigen—in humans) 
until the need for more candidate immune target genes had been pointed out [8]. For example, gene 
candidate approaches related to innate immunity e.g., toll-like receptors or cytokines, [9,10] as well as 
genomic approaches [11–13] have recently been developed on wild birds, fishes and rodents to 
evaluate the influence of molecular mechanisms on susceptibility to infectious diseases. Investigating 
spatio-temporal variations of allele/single nucleotide polymorphism (SNP) frequencies at these 
genes/loci provided further insight into the potential role of these polymorphisms in the susceptibility 
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to infectious diseases [14], the epidemiological consequences of this variability [15] and the evolutionary 
mechanisms (selection, migration, drift) maintaining immune gene diversity [16,17]. Strikingly, only 
recently has this evolutionary perspective been explored in human studies [18]. 
1.2. Hantavirus Infection and Disease 
Humans are ―incidental hosts‖ for hantaviruses and are typically infected via contaminated aerosolized 
secretions (feces, urine, saliva) of the reservoir animals, which mainly include rodents, but also shrews, 
moles and bats though no human connection has been established yet with hantaviruses from the three 
latter host groups. The clinical course of human hantaviral infections varies greatly according to the 
different hantaviruses, ranging from no disease to mild course and low case-fatality rate (0.1% in 
Puumala virus –PUUV– infection) to severe course up to 40%–50% in Sin Nombre –SNV– and Andes 
–ANDV– virus infections [19,20]. In addition, large variation in clinical severity exists among patients 
for a given hantavirus species. Serological surveys conducted in Europe and in the Americas have 
demonstrated the presence of antibodies in humans who had no history of clinical disease  
with hemorrhagic fever with renal syndrome (HFRS) or hantavirus cardiopulmonary syndrome 
(HCPS) [19,21]. This suggests that even for some human pathogenic hantaviruses, some infections 
could be subclinical. More specifically, it is known that the course of nephropathia epidemica (NE),  
a mild form of HFRS in patients infected with PUUV is highly variable, ranging from asymptomatic [22] 
to occasionally fatal disease [23]. Hypotension up to clinical shock are for example present in less  
than 10% of the hospitalized patients, 5% may require dialysis, while some fatal outcomes have been 
reported less than 0.1% [24,25]. Although complex interactions are likely to underlie this variability, 
the importance of host genetics in the susceptibility to hantavirus infections and in the severity of the 
disease has begun to gain evidence. 
In rodents, which are the reservoirs of pathogenic hantaviruses, infection is persistent [26,27] and 
mainly asymptomatic but see [28–30]. Nevertheless rodents differ in their probability of being infected 
with their associated hantavirus e.g., [31]. Experimental infections have confirmed that the outcome of 
a given hantavirus infection could vary among rodents [32,33]. As in humans, the genetic background 
of the reservoirs could mediate this variability. 
1.3. Potential Applications 
We review the studies on associations between immunity-related gene variation (coding sequence 
and levels of transcription) and the outcomes of hantavirus infection, considering both the probability 
of getting infected and the severity of the diseases, in humans and rodents. These results are of major 
medical importance because they can help predicting disease progression in hospitalized patients and 
can lead to better therapeutics and vaccines. Furthermore, they may improve our understanding of the 
epidemiology of hantaviruses, by providing a more precise comprehension host switching and ultimately 
hantavirus transmission from reservoirs to humans. 
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2. Impact of Genetic Factors in Human Hantavirus Infections 
2.1. Sequence Polymorphism of Immunity-Related Genes and the Severity of Human Hantavirus Infections 
Gene candidate approaches have been developed to emphasize associations between human 
genotypes and the clinical severity of hantavirus infections, with the aim of deciphering the genetic 
factors that have a major influence on the outcome of these infections. Immunogenetic investigations 
have mainly focused on the human leukocyte antigen (HLA) system, and on genes encoding molecules 
associated with this complex such as the C4A component of the complement system. Few other 
additional genes have been investigated. We detail the results of these studies below (see Table 1  
for a summary). 
HLA system. It encompasses 224 genes in a 3.6-Mb region of chromosome 6 in humans [34]. It is 
an essential component of the immune system with about 39.8% of these genes being immunity-related 
ones. Forty of the total genes belonging to the HLA system encode leukocyte antigens. The role of 
these cell-surface antigens is to present pathogen-derived antigens to T cells and to initiate acquired 
immune responses [35]. Some of these genes (i.e., class I and class II genes) are among the most 
polymorphic in humans. For example, more than 100 allelic variants have been identified in human 
populations at the HLA-B and HLA-DRB1 loci (IMGT/HLA database, [36]). Many associations 
between alleles or combinations of alleles and susceptibility to infectious and autoimmune diseases 
have been described in humans e.g., [4,37]. 
For HFRS and HCPS, risk HLA haplotypes have been identified according to the following clinical 
and laboratory parameters of disease severity: treatment time at hospital (overall severity), weight 
change during hospital care (amount of fluid retention during oliguric phase), need of dialysis, lowest 
systolic blood pressure, presence of shock, increase of plasma creatinine and urea (severity of acute 
kidney injury—AKI), decrease of platelets (thrombocytopenia) and increase in blood leukocyte count 
(leukocytosis) [19]. There is a great geographic variability in the HLA alleles and haplotypes associated 
with hantavirus disease severity, both for HLA class I (HLA-B) and class II (HLA-DRB) genes. 
In Finland, the individuals with HLA alleles HLA-B*08 and DRB1*0301 are likely to have the 
most severe form of the PUUV infection with lower blood pressures, higher creatinine [38] and more 
virus excretion into the urine and into the blood [39]. On the contrary, individuals with HLA-B*27 
have a benign clinical course [40]. In Slovenia, the HLA-DRB1*15 haplotype was more frequent in 
patients with severe PUUV-HFRS progression than in patients with a mild course of the disease [41]. 
In China, the most severe HFRS cases due to Hantaan virus (HNTV) were associated with the 
presence of HLA-B*46 allele and HLA-B*46–DRB1*09 or HLA-B*51–DRB1*09 haplotypes [42].  
In contrast, the HLA-DRB1*12 allele was more frequent in patients with a mild form of the disease 
but this relation was only marginally significant [43]. 
In the USA, the HLA-B*3501 and HLA-DRB1*1402 alleles are associated with increased risk of 
severe Sin Nombre (SNV)-induced HCPS [43–45]. In another study, HLA-B*35-restricted memory  
T-cell responses were related to mild disease outcome in HCPS due to Andes virus [46]. In the Chilean 
population, HLA-DRB1*15 was associated with a mild form of HCPS due to Andes virus whereas 
HLA-B*08 was again correlated with the severe course of this disease [47]. 
Viruses 2014, 6 2218 
 
 
Table 1. Immunity-related genes associated with the severity of hantavirus disease in humans. 
 Gene Country Haplotype Expression Hantavirus 
Relevance with Disease Severity 
(−: Mild form; +: More Severe) 
Relevance with Infection  
(P: Protective; R: Risk) 
HFRS 
HLA Finland HLA-B*08  PUUV +  
  HLA-DRB1*0301  PUUV +  
  HLA-B*27  PUUV −  
 Slovenia HLA-DRB1*15  PUUV +  
  HLA-DRB1*13  PUUV & DOBV + (PUUV) PUUV > DOBV 
  HLA-B*35  PUUV & DOBV + (DOBV) DOBV > PUUV 
  HLA-B*07  PUUV  P 
 China HLA-B*46  HTNV +  
  HLA-B*46/DRB1*09  HTNV + R 
  HLA-B*51/DRB1*09  HTNV +  
  HLA-DRB1*12  HTNV − P 
TNF Finland −308  PUUV +  
 Belgium −238  PUUV +  
C4A Finland Deletion  PUUV +  
HPA-3 China 3b  HTNV + R 
PAI-1 Finland GG  PUUV +  
Gp1A Finland C  PUUV +  
VE-CDH5 Russia *T/*T  PUUV +  
GATA-3 Finland  Higher PUUV +  
IL1-RA China */*  HTNV  R 
IL1-1b China −511  HTNV  R 
IL1 Finland x  PUUV None  
HPA-1 China x  HTNV None  
CD3e Finland  x PUUV None  
T-BET Finland  x PUUV None  
HCPS 
HLA US HLA-B*3501  SNV +  
  HLA-DRB1*1402  SNV +  
  HLA-B*35  ANDV −  
 Chile HLA-B*08  ANDV +  
  HLA-DRB1*15  ANDV −  
TNF Brazil −308G/A  ARAV +  
+ and − respectively indicate that severe or mild forms of hantavirus disease are associated with genetic variations; P and R respectively indicate that genetic variations 
confer protection or are associated with higher risk of hantavirus infection. 
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Thus, different hantaviruses seem to be processed differently through the same HLA molecules 
resulting in mild or severe outcomes of the disease. Studies on the genetic factors associated with 
disease severity due to different sympatric hantaviruses confirm this statement. In Slovenia for 
example, both PUUV and Dobrava virus (DOBV) are present and cause HFRS. PUUV-infected 
patients tend to have more frequently (32%) HLA-DRB1*13 haplotype than DOBV-infected patient 
(18%), especially in the severe form of PUUV disease [41]. Furthermore, DOBV-infected patients 
have a significantly higher prevalence of HLA-B*35 than PUUV-infected patients This allele was 
marginally associated with a fatal outcome of the DOBV-infected patients [41]. 
It is interesting to note that most of these alleles/haplotypes associated with severity of hantavirus 
disease are linked to abnormal immune responses or autoimmune diseases see references in [38,48]. 
Individuals with the haplotype HLA-B*08–HLA-DRB1*0301 are prone to normal or increased 
humoral immune response and a low T-cell immune responsiveness [49]. In contrast, the HLA-B*27 
allele is associated with decreased production of TNF and IFN-γ by T cells [50]. These immunogenetic 
studies thus provided the first lines of evidence that the pathogenesis of hantavirus infection is likely  
to imply the immune system of the host. Further investigations are required to decipher the  
mechanisms linking HLA class I and class II gene polymorphism, T cell responses and the severity of  
hantavirus infection. 
The tumor necrosis factor (TNF) cluster belongs to the class III region of the HLA complex and 
contains genes that encode two cytokines, TNF and LTA, and LTB, a receptor that forms heterotrimers 
with LTA [34]. An allele associated with high production of TNF (polymorphism at position −308) 
correlates with the severe clinical course of PUUV infection in Finnish patients [51] and is strongly 
expressed in kidneys of PUUV-infected humans [52]. TNF gene is partly involved in severe PUUV 
disease but is a less important risk factor than the HLA-B*08–HLA-DRB1*0301 haplotype [23].  
In Belgium, patients with the low-producer allele of TNF (polymorphism at position −238) had a more 
severe clinical course [53,54]. In Brazil, the high-producing TNF-a 2 allele (−308G/A) was more 
frequent in HCPS patients than in individuals with antibodies but without a history of HCPS, 
suggesting that this allele could represent a risk factor for developing HCPS [55]. In Brazil, this TNF-a 
2 allele association, unlike in Finland, was independent of the HLA-B*08–HLA-DRB1*0301 linkage 
disequilibrium. In the same study, no association was found between TNF alleles and the severity or 
case-fatality-rate of HCPS [55]. 
C4A. Deletion within the C4A gene encoding the C4A component of the complement system is 
invariably associated with the HLA-B*08–HLA-DRB1*0301 haplotype [56,57]. This is of interest 
since there is good evidence that complement activation contributes to the pathogenesis of PUUV 
infection [56]. Levels of the soluble terminal SC5b-9 complex were higher, and C3 levels were lower 
during the acute stage than during convalescence, especially in patients with chest x-ray abnormalities. 
These changes had a significant correlation with clinical and laboratory parameters of disease severity. 
Polymorphism within genes encoding cytokines may modulate cytokine production during 
inflammation and therefore influence the outcome of hantavirus infections. Only few studies have 
addressed this question. Mäkelä et al. [58] have analyzed polymorphism of the IL-1 family genes. 
They did not find any evidence of allele frequencies or genotypes affecting the clinical course of 
PUUV infections. 
Viruses 2014, 6 2220 
 
 
Polymorphisms of platelet glycoprotein IIb/IIIa alloatigen (HPA1/HPA3) have been investigated 
and HPA-3, but not HPA-1, was more frequent in Chinese patients with severe than mild HFRS [59]. 
In Finland, plasminogen activator inhibitor (PAI-1) and platelet GP1a were associated with severe 
PUUV infection [60]. 
Finally, the prevalence of the VE-cadherin CDH5 genotype *T/*T was significantly higher in 
Russian patients with the severe form of HFRS due to PUUV than in other patients. Missense mutation 
c.1550T > C within the VE-cadherin gene could increase the desquamation process of endothelial cells 
and lead to a severe form of HFRS with complications [61]. 
2.2. Variability in Immunity-Related Gene Expression and Severity of Human Hantavirus Infections 
Several associations between serum levels of cytokines TNF IL-6, IL-2, IL-8, IL-10, IFN-γ,  
see [62–66] or the intensity of platelet β3 integrin [67] and disease severity have been shown for 
PUUV, HTNV and DOBV infections. Genetic determinisms modulating the mRNA expression levels 
of the genes encoding these molecules could represent important risk factors of hantavirus disease 
severity. Nevertheless, only a single study has compared the levels of mRNA expression of some of 
these genes among patients exhibiting different progressions of hantavirus disease. Briefly,  
Libraty et al. [63] followed the mRNA expression levels of a T-cell associated gene (CD3e), a type 1 
cytokine transcription factor (T-BET) and a type 2 cytokine transcription factor (GATA-3) in daily 
urine samples to identify risk factors for severe PUUV HFRS during acute illness (AKI). They found 
that only GATA-3 mRNA expression was higher in patients developing severe AKI than in those with 
mild AKI. They concluded that this clinical severity could be explained by excessive type 2 T-cell 
responses compared to type 1 T-cell responses in the kidneys. Alternatively, GATA3/Th2 response 
may be a negative feedback to temper immunopathology. In the near future, similar studies in other 
countries, for other genes and other hantavirus species, could help identifying a large array of 
immunogenetic factors modulating the severity of human hantavirus infections. 
2.3. Polymorphism of Immunity-Related Genes and Human Susceptibility to Hantavirus Infections 
As shown above, most of the immunogenetic studies on human hantavirus infections have looked 
for associations between human immunogenetics and disease severity. Only few of them investigated 
factors that could contribute to susceptibility to hantavirus infection. Their results have shown that all 
genetic variations modulating hantavirus infection risk were also involved in disease clinical severity. 
Hence, HLA-DRB1*09 and HLA-B*46–DRB1*09 were more common in Chinese patients with 
HTNV-induced HFRS than in healthy individuals [48,68]. Moreover, non-carriage of the interleukin-1 
receptor antagonist (IL-1RA) allele 2 and the IL-1b (−511) allele 2 [58] as well as HPA-3 b allele [59] 
were more frequent in HFRS patients than in seronegative controls. These alleles/haplotypes could 
thus be identified as genetic risk factors associated with the susceptibility to hantavirus infections [59]. 
In turn, HLA-B*07 and HLA-DRB1*12 could have a protective role, respectively, against PUUV 
infection in Slovenia [69] and HTNV infection in China [68]. 
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3. Impact of Immunity-Related Genes on the Risk of Hantavirus Infection in Rodents 
3.1. Kinetics of Immunity-Related Gene Expression During Hantavirus Infection in Rodents 
The kinetics of immunity-related gene expression has been analyzed during experimental hantavirus 
infection for several rodent/hantavirus models. As the course of infection may differ among 
individuals [32,33,70], comparing these dynamics turned out to be relevant to the identification of 
immunogenetic variations underlying these differences. For now, two main questions have been 
investigated and are summarized below: do variations in immunity-related gene expression mediate 
sex differences in hantavirus infections? Do they explain the persistence or the clearance of hantaviruses in 
rodent reservoirs? 
3.1.1. Immunity-Related Gene Expression and Sex Differences in Hantavirus Infections 
Longitudinal studies in reservoirs of hantaviruses have highlighted that in wild rodent populations, 
more males than females are infected in mature animals only, but not in subadult, i.e., non-breeding 
ones e.g., [71–74]. Sex-based differences in gene expression could modulate these patterns in mature 
rodents. Klein et al. [75] revealed that about 1800 genes with known function were differentially 
expressed between sexually mature male and female Norway rats (Rattus norvegicus) after 
experimental Seoul (SEOV) infections. Up to 180 were immunity-related genes that showed a pattern 
of up-regulation into the lungs of females compared to males. Associated functions included 
inflammatory (e.g., TNF-α, TNF-αR, IL-1R, IL-1RAcP) and antiviral (eIF-2α, IFN-γR, STAT-6, 
(IRF)-1) responses as well as MHC, Ig and T cell marker proteins [75,76]. In addition, gene expression 
of heat shock proteins was higher in SEOV infected males than in females, indicating a more elevated 
cellular stress [75]. These studies therefore suggest that both differences in innate and acquired  
immunity-related gene expression could mediate dimorphic responses in rodent reservoirs to 
hantavirus infections. 
3.1.2. Immunity-Related Gene Expression and Persistence/Clearance of Hantavirus Infections 
Hantaviruses often cause an acute infection followed by a persistent phase in reservoir rodents. 
However, variable patterns of infection have been observed among infected individuals, even within a 
given reservoir species. For example, Botten et al. [77] revealed two distinct patterns of infection 
(based on the levels and the distribution of viral RNA) during the persistent phase of SNV infection in 
deer mice. Some individuals exhibited a ―restricted‖ pattern of viral replication and antigen expression 
(antigen expression was for example detected in fewer than three of the tissues examined), while 
others showed a ―disseminated‖ pattern of infection (antigen expression was observed in five to nine of 
the tissues examined). Studying the kinetics of rodent gene expression following hantavirus infection 
has helped understanding these phenomena. In particular, it allowed discriminating several mechanisms 
explaining hantavirus persistence, including immune evasion, direct suppression or modification of host 
immune responses. 
The comparison of cytokine gene expression profiles between T cell lines in acutely and 
persistently infected deer mice revealed an increase of TGF-β and FoxP3 mRNA expression and a 
Viruses 2014, 6 2222 
 
 
decrease of IL-10 and IL-4 expression during the persistent phase of SNV infection in most of the lines 
studied [78]. Similar results were obtained by Easterbrook et al. [79,80] based on the study of the 
persistent phase of SEOV infection in male Norway rats. Increased levels of FoxP3 and TGF-β mRNA 
expression were observed in the lungs of SEOV infected rats compared to uninfected ones. In contrast, 
the levels of IL-10, IL-1b, IL-6 and TNF gene expression were reduced. Easterbrook et al. [80] also 
showed using SEOV infected male Norway rats that proinflammatory responses were elevated  
(e.g., high expression of IL-6, CCL2 and CCL5 genes) and that regulatory responses (e.g., expression 
of TGF-β and Fox-P3) were not induced in spleens, an immunity-related organ where hantavirus 
replication is low. Similar results were observed following immunity-related gene expression in spleen 
of deer mice infected with ANDV [33], although responses were more heterogeneous among 
individuals. This was probably due to the fact that rodents were more inbred in this experiment than in 
the one described above. These common modifications of immunity-related gene expression during the 
persistent phase seemed to depend on a concomitant increase of regulator T cells. By suppressing 
proinflammatory responses, they could on one hand contribute to the tolerance of reservoirs to 
hantavirus infection and their associated pathogenesis, and on the other hand, lead to hantavirus 
persistence in the host. 
3.2. Immunogenetics and Rodent Susceptibility to Hantavirus Infections 
3.2.1. Sequence Polymorphism of Immunity-Related Genes between Reservoir and Non-Reservoir 
Species and Their Association with Susceptibility to Hantavirus Infection 
Rodent species exhibit different capacities as reservoirs of hantaviruses. For example, hantavirus 
infections are supposed to be asymptomatic and chronic in their rodent reservoirs, however some 
rodent species are known to be non-reservoirs of hantaviruses. The Syrian hamsters (Mesocricetus 
auratus) and the house mice for example do not carry any hantavirus in the wild and are known to 
mimic human pathogenesis or to die when being infected respectively with ANDV and HTNV see 
references in [81]. The fact that phylogenetically related rodent species share similar properties 
allowing a given hantavirus to replicate compared to distant related ones [82] is a first argument 
indicating that genetics might modulate these variations. Inter-specific molecular differences in the 
genes encoding proteins involved in virus entry into host cells are good candidates to test this 
hypothesis see for example [5]. 
To date, no receptor for hantaviruses has been defined nor suggested in animal host species.  
Our current knowledge is based on in vitro or in vivo analyses conducted on laboratory rodent species 
that are not reservoirs of hantaviruses. Therefore, mechanisms of viral entry in reservoir animals 
remain unknown. Nevertheless, it could be interesting to analyse the polymorphism and the 
phylogenies of the genes encoding these receptors or other proteins. Several candidate genes can be 
identified from the literature. The gene fragment encoding the plexin–semaphorin–integrin (PSI) 
domain of the αvβ3 integrin is involved in viral attachment for several pathogenic hantaviruses in 
humans [83–87]. Single amino acid changes performed through mutagenesis were shown to modify 
hantavirus recognition and subsequent infection of culture cells. Raymond et al. [86], then Matthys et al. 
[88] showed that mutagenizing the murine PSI domains to homologous human residues (substituting 
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serine for a proline—S32P or asparagine to aspartic acid—N39D respectively) allowed these mutant 
polypetides to inhibit hantavirus infection (NY-1V and ANDV respectively). Among other potential 
candidates, the β1 integrin, the complement decay-accelerating factor (DAF) and GC1QR (also known 
as C1QBP) should be investigated because studies have emphasized their potential role in hantavirus 
entry into cells (Vero and human cells) [84,89,90]. Further phylogenetic analyses of the genes 
encoding these receptors could provide new information on their potential implication in hantavirus 
entry in reservoir cells. 
3.2.2. Sequence/Expression Variability of Immunity-Related Genes between Rodent Populations  
Sampled in Endemic and Non-Endemic Areas and Their Associations with Susceptibility to  
Hantavirus Infection 
Several works based on experimental infections of rodents have revealed that hantavirus infectivity 
varies among individuals of a same species [31–33,77,91]. Although infection is most of the time 
asymptomatic, changes in tissue morphology similar to those associated with SNV infections in 
humans (pulmonary oedema, periportal hepatitis) have been reported once in white-footed mouse, 
Peromyscus leucopus, experimentally infected with New-York virus [92]. Similar histopathologies 
were observed in wild caught deer mice, Peromyscus maniculatus, infected with SNV [93]. Strong 
correlations were observed between the detection of pulmonary histopathological findings and the 
amount of viral antigen detected in organs, suggesting that these morphological changes were caused 
by SNV infection. These results have nevertheless to be taken carefully as such evidence of lesions 
remain rare compared to the large number of experimentally infected rodents which did not show any 
sign of pathology. Kallio et al. [31] exposed naive bank voles, Myodes glareolus, to beddings 
previously contaminated by PUUV. They showed that infection outcomes were highly variable among 
recipient voles, independently of sex or age. Guivier et al. [94] evaluated whether immunity-related 
gene polymorphism could explain these differences. Unfortunately, no significant associations could 
be detected between infection success and immunity-related gene polymorphism of these bank voles. 
Dqa Mhc class II gene was monoallelic among the 101 bank voles analyzed from this experimental 
dataset. The relative risk associated with Mygl-Drb*117 was high (RR = 4.82, p = 0.062) although not 
significant. This absence of relationship was likely to be explained by the loss of genetic variability 
that occurred during the long-term multigenerational captivity of these rodents [94]. 
Other studies investigated the influence of immunogenetic background on hantavirus risk in 
rodents, using natural populations sampled in endemic and non-endemic areas for hantaviruses. To our 
knowledge, such studies have only been conducted on bank voles, the reservoir of PUUV. Patterns of 
spatial genetic differentiation have been contrasted between presumed neutral markers and immunity 
related genes. Comparing patterns of population genetic differentiation observed for these types of 
genes allows for detecting signatures of contemporary selective processes [95]. Associations between 
immunity-related gene polymorphism and PUUV infectious status (infected/non-infected) are next 
conducted to infer whether such selection might be driven by M. glareolus/PUUV interactions.  
These studies are summarized below. 
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3.2.2.1. Mhc Class II Genes: Drb, Dqa 
Studying associations between Mhc haplotypes and hantavirus infections in wild rodents appeared 
an obvious aim in light of the human medical literature previously cited. Studies focused on the class II 
Drb and Dqa genes because of their high levels of polymorphism. Class I genes are more difficult to 
examine because of the large number of duplicated copies, which prevents the amplification of all 
alleles and blur the assessment of genotypes. 
About 350 bank voles coming from 38 European localities have been genotyped for the cytochrome 
b (mitochondrial marker, supposed to evolve neutrally), Dqa and Drb class II genes [96,97]. Haplotype 
distributions were analyzed and compared between genes to study the relative influence of history 
(bottleneck, migration, expansion) and natural selection forces (including PUUV mediated selection) 
acting on Mhc genes. A spatial analysis of molecular variance (SAMOVA) was applied to find 
population clusters that maximize molecular variance among population groups [98]. Clusters were 
defined independently for each gene. High levels of incongruence were observed, both between Mhc 
and mitochondrial genes and between Dqa and Drb genes Figure 1 [99]. For example, the 10 clusters 
found based on Drb haplotype distribution did not correspond neither to the phylogeographic groups 
expected from the European colonization/recolonization history of the bank voles (assessed via 
cytochrome b analysis) [100], nor to PUUV (presence/absence of the virus or distribution of the 
different lineages previously described by Nemirov et al. [101]). These results suggested that selection 
is likely to influence the evolution of the Drb Mhc class II gene, and that multifactorial pressures 
(including other pathogens for example) rather than PUUV risk alone mediate this selection.  
The distribution of Drb Mhc class II gene polymorphism should therefore not be simply used to infer 
the chance of PUUV infection in bank voles. 
Genotype-phenotype associations were examined in large European datasets (about 200 bank  
voles, 65 PUUV-seropositive ones) that included bank voles sampled in Fennoscandia (Finland and 
Sweden), and in French and Belgian (the Ardennes and the Jura) PUUV-endemic areas. Dqa gene 
polymorphism did not influence the probability of bank voles being infected with PUUV in most of 
geographic localities considered [94]. However, in the French Jura (corresponding to a recently 
identified area of PUUV endemicity), significant negative associations were detected between the 
presence of anti-PUUV antibodies and both Cgl-DQA-05 and Cgl-DQA-12 alleles (RR = 0.21 and 0.57, 
respectively). In a lesser extent, Cgl-DQA-09 and Cgl-DQA-11 were more present in PUUV infected 
voles (positiveassociation, RR = 2.83 and 2.07 [102]). These results have nevertheless to be taken 
cautiously as only nine bank voles among the 98 studied were PUUV seropositive in this sampling. 
Drb haplotypes significantly discriminated seropositive bank voles from seronegative ones, but 
only in the Fennoscandian localities. The allele Mygl-Drb*03 exhibited a high relative risk (RR) in 
Finland (Ilmajoki, RR = 3.73). The allele Mygl-Drb*93 was associated with high RR in Sweden 
(Västerbotten, RR = 2.95). None of these alleles were found in the Ardennes [94]. None of the other 
alleles detected in the French and Belgian Ardennes were associated with the probability for a rodent 
to be PUUV infected. A recent population genetic analysis comparing the patterns observed for neutral 
microsatellites and the Drb gene in localities sampled in PUUV endemic and non-endemic areas 
Northand South French Ardennes, see [103] did not reveal any signatures of selection at this Mhc  
class II gene [97]. 
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Figure 1. Distribution of Mhc (a) Dqa and (b) Drb exon2; and (c) mitochondrial cytochrome b 
(cyt b) polymorphism in M. glareolus populations over Europe (from [95,98]). Spatial  
clustering was defined using Spatial Analysis of MOlecular VAriance (SAMOVA). Populations 
belonging to a same cluster are represented by a same symbol. 
  
(a) (b) 
 
(c) 
Altogether, these results mirror in some extents what was previously described in humans. 
Associations between the presence of particular Mhc haplotypes and PUUV antibodies were detected 
and showed a high level of geographic variability, probably reflecting local adaptations between hosts 
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and viruses. These adaptations seem stronger in Fennoscandian localities (detection of associations and 
signatures of selection), probably because the levels of PUUV prevalence are higher and possibly 
because co-adaptation between M. glareolus and PUUV has a longer history. Whether these Mhc 
haplotypes directly confer a higher susceptibility or PUUV resistance in bank voles (or in other rodent 
species) can not be determined based on these field studies solely. 
3.2.2.2. Tnf 
Guivier et al. [16,104] have analyzed the distribution of Tnf promoter polymorphism in M. 
glareolus populations over Europe (Sweden, Finland, Germany, France, and Czech Republic). They 
hypothesized that spatial genetic differentiation between endemic and non-endemic areas could be 
mediated by PUUV and that polymorphism should reflect variation in Tnf gene expression. Sixteen 
single nucleotide polymorphisms (SNPs) were detected, among which three exhibited frequencies that 
allowed performing further statistical analyses (SNP −390 C/T, −296 G/A et −302 GG/~~). Two of 
them showed interesting patterns with regard to the variation of allelic frequencies between localities. 
Genetic differentiation indices between France and Czech Republic or between all pairs including the 
Finnish locality were significant. The allele −296G and the genotype −302~~ (~meaning deletion) were 
observed at low frequencies in France, Czech Republic and Slovakia but were highly represented in 
Finland where PUUV is highly prevalent. 
Further analyses of associations between these SNPs and both Tnf splenic expression or PUUV 
infection suggested that TNF response could also be important in M. glareolus/PUUV interactions. 
The relative risk RR, see [105] of PUUV infection associated with these SNPs varied between 0.93 
(Finland) and 2.82 (French Ardennes), indicating that voles carrying rare alleles (−296 G or −302~~) 
were at least twice more likely to be infected by PUUV than voles exhibiting common alleles [104]. 
Rohfritsch et al. [97] carried out a population genetic analysis to look for selection acting on the  
Tnf promoter between the endemic and non-endemic localities of the French Ardennes (North-South 
transect). They revealed a higher genetic differentiation at site −296 than expected under the neutral 
assumption, especially when comparing northern (endemic) and southern (very low PUUV seroprevalence) 
localities. Therefore, population genetics analyses have revealed that the distribution of particular Tnf 
promoter SNPs between bank vole populations could not be explained by neutral evolutionary forces 
only. On the other hand, associations were detected between these SNPs and the risk of PUUV 
infection in bank voles. Selection acting on Tnf promoter could therefore be linked to PUUV, either 
indirectly, or potentially directly. Indeed, several ongoing studies are providing evidence of negative 
effects of PUUV on different components of vole fitness, including survival [28,29,71]. 
In Europe, polymorphism at site −296 was significantly associated with the relative expression of 
Tnf gene detected in the spleen [104]. Homozygotes −296 A/A had higher mRNA levels of Tnf gene 
than the −296 G/G heterozygotes (Figure 2). 
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Figure 2. Relationship between variation at position −296 of the Tnf promoter and the  
log-transformed relative expression of Tnf (here: log (Tnf mRNA)) in European bank voles. 
Relative expression was estimated as [(ETar + 1)
CpTar
]/[(ERef + 1)
CpRef
] with ETar, ERef, CpTar 
and CpRef being, respectively, the average efficiencies of the target (Tnf) and reference  
(β-actin) genes and the crossing points of the target and reference genes (see [104]). 
ANOVA was first performed and emphasized significant differences of Tnf relative  
expression among Tnf promoter genotypes (ANOVA, F2,75 = 4.002, p = 0.022). Further 
Tukey-Kramer tests showed that voles with genotype -296 A/A exhibited a significantly 
higher relative expression of Tnf than those with −296 G/G genotype (Tukey–Kramer test,  
p = 0.016). Boxes represent the first and third quartiles of the distribution. Horizontal black 
lines correspond to medians. The vertical dashed lines correspond to 1.5 times the  
interquartile range. 
 
mRNA levels were next compared between localities (Figure 3a). They were significantly lower in 
bank voles sampled in PUUV endemic areas (Finland, French Ardennes) than in a locality where 
PUUV has not yet been recorded (Eastern part of Czech Republic). Using the North-South transect in 
the Ardennes, Guivier et al. [16] also revealed that higher levels of Tnf relative expression were 
associated with lower PUUV loads in wild bank voles [104]. 
TNF plays an important role in immune responses but also induces pathophysiologic changes. It has 
therefore been suggested that it could mediate two types of responses against PUUV: resistance when 
highly produced and tolerance when weakly produced. The latter corresponds to an adaptive process 
limiting pathogeneses at the expense of pathogen growth or reproduction [104,106]. Altogether, the 
studies described above have shown that higher levels of Tnf gene expression could limit PUUV 
infection in bank voles. They also evidence that some geographic variability in the level of Tnf gene 
expression, genetically determined by Tnf promoter polymorphism, could reflect the co-adaptation 
history between PUUV and bank voles. In endemic areas with continuously high PUUV prevalence 
(e.g., Finland, French Northern Ardennes), strong co-adaptation histories between M. glareolus and 
PUUV could have selected for higher levels of tolerance to PUUV infections (i.e., lower levels of TNF 
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production) than in populations where prevalence levels of PUUV are low (Czech Republic, French 
Southern Ardennes). 
Figure 3. Geographic variations of the levels of Tnf relative expression (see above for  
detailed formula) detected in bank voles from four European localities [16]. A multiple  
linear regression with selection model procedure was performed; locality was the only  
significant effect detected (F3,132 = 5.204; p = 0.002). Boxes represent the first and third 
quartiles of the distribution. Horizontal black lines correspond to medians. The vertical 
dashed lines correspond to 1.5 times the interquartile range. The circles represent the  
values superior and inferior to 1.5 times the interquartile range. 
 
3.2.2.3. Other Genes (Tlr4, Tlr7, Mx2, β3 Integrin) 
Coding sequence polymorphism and gene expression of few other candidate genes have also been 
compared using the French Ardennes design (North-South transect). Sequence polymorphism of the 
genes encoding TLR4 (exon3), TLR7 (exon3), Mx2 (exons 5 to 14) and the PSI domain of β3 integrin 
has been analyzed for about 300 bank voles sampled in the French Ardennes. Respectively 10, 1, 4 and 
no SNPs were detected in these individuals. Population genetic analyses did not reveal any signature  
of selection acting on these genes when comparing endemic (Northern) and non-endemic (Southern) 
localities [96]. 
Like other Mx proteins, Mx2 is an interferon-induced gene product involved in antiviral response. 
Because Mx2 is known to limit PUUV replication in humans and in cell cultures [106], and to induce 
pathological symptoms when overproduced [108,109], Guivier et al. [16] analysed the variability of 
Mx2 gene expression between areas of high and low PUUV seroprevalence in the French Ardennes. 
Similar results as those observed with Tnf were described. The mRNA levels of Mx2 genes were 
negatively correlated with PUUV loads in infected bank voles, corroborating the idea that Mx2 might 
limit PUUV replication in bank voles. They also showed that bank voles from forests (higher PUUV 
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seroprevalence) had lower levels of Mx2 gene expression than voles living in fragmented hedge 
networks lower PUUV seroprevalence, higher genetic drift, see [110]. Again, these lower levels of 
expression may be considered to reflect tolerance mechanism against pathogens (including PUUV). 
Applying immunogenetics to the study of M. glareolus/PUUV interaction in natural populations has 
provided new arguments in favour of tolerance mechanisms evolving in bank voles, directly or 
indirectly mediated by PUUV. Histories of host-pathogen co-adaptation, differences in biotic and 
abiotic environmental conditions are factors that could maintain and shape variation in the amplitude 
of tolerance among bank vole populations. These conclusions are derived from correlative patterns 
based on the study of few immunity-related genes. Genomic approaches or experimental approaches 
will help confirm these results and detail the mechanisms underlying tolerance to PUUV and its 
variation over Europe. In future, similar studies should be conducted on other rodent/hantavirus 
models to test if this phenomenon may be generalized at a larger evolutionary scale. 
4. Discussion: The Evolutionary Perspectives 
4.1. Geographic Distribution of Susceptible Haplotypes and the Risk of Hantavirus Emergence 
As detailed above, the analyses of genetic variation modulating the susceptibility, hantavirus 
replication or severity of disease, have usually been performed at the population level (one locality or 
one country) in reservoirs or in humans. Congruent or incongruent patterns may exist when results are 
compared between populations. Nevertheless, no or few lessons have been learned from these 
comparisons but see in rodents, [16,104]. To our knowledge, there is no real wish to conduct a 
worldwide human case study. Until now, research focused on a single country or on a specific hantavirus. 
Including a wide range of populations concerned with one or several specific hantaviruses could provide 
more generic conclusions on the role of immunogenetics on human susceptibility to hantaviruses. 
Furthermore, such research would have important consequences in terms of public health.  
In humans, allele frequencies are now available for several millions of single nucleotide 
polymorphisms (SNPs) in worldwide populations [111,112]. These data have been used to evaluate 
genome-wide association studies for many diseases 250 studies referenced in 2012, see [18]. It would 
be worth exploiting these genomic data to evaluate the genetic basis of human susceptibility to 
hantavirus infection at a large genomic scale, and to explore potential geographic variations  
(e.g., between the New and Old Worlds, or between European and Asian countries). Ultimately, it 
could be envisaged to map genetic risks of HFRS across Europe and Asia or HCP in the Americas. 
These distribution maps could help targeting regions where HFRS risk is high but still underestimated 
or unrecognized. Such regions would be the first priority for informing health professionals and 
developing communication strategies to the general public. 
Comparison of the geographic distribution of allele frequencies for ―neutral‖ SNPs and SNPs that 
are associated with susceptibility to hantaviruses or severity of hantaviral disease may highlight the 
historical and selective evolutionary forces acting on these candidate SNPs and shaping the observed 
distribution of polymorphism. Several studies have been conducted in this framework for different 
immunity-related genes. Barreiro et al. [113] considered two innate immunity-related genes sharing 
very close physical vicinity (Cd209 and Cd209l). They emphasized that history and selection had lead 
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to different outcomes of innate immunity-related gene polymorphism. Traces of ancient population 
structure in Africa and strong functional constraints explained the diversity of Cd209 gene while 
balancing selection was likely to generate the high level of diversity observed at the Cd209l gene.  
A major difficulty may reside in the identification of the selection pressure acting on candidate genes 
and shaping the distribution of their polymorphism at large geographical scales see for example in 
mammals [96]. Nevertheless, some significant examples exist, including the comparative evolutionary 
histories of thalassemia and malaria [114]. The application of concepts of evolutionary biology to the 
study of immunogenetic factors affecting susceptibility to hantaviruses or clinical course of hantaviral 
disease in humans should be promising approaches in the near future. 
4.2. Evolution of Tolerance in Rodents and Its Epidemiological Consequences 
Several studies have emphasized the high level of variability in reservoir susceptibility to a given 
hantavirus or in their ability to limit hantavirus replication [16,104,115]. These results may be 
interpreted in terms of tolerance to hantavirus as some of the molecules involved in this process can 
lead to immunopathologies when over-produced (e.g., TNF-α, Mx2). In turn, this individual variability 
of tolerance can strongly impact hantavirus epidemiology. Individuals exhibiting high levels of 
tolerance will play a major role in hantavirus persistence, dissemination and transmission dynamics. 
Tolerance has neutral or positive effects on pathogen fitness [106,116]. Tolerant individuals may hence 
support higher viral loads, leading to higher quantities of viral particles potentially excreted into the 
environment. Such individuals might therefore be considered as super-spreaders of hantavirus [117].  
It appears important to identify these super-spreaders within and between reservoir populations/species. 
This would improve our knowledge about hantavirus eco-epidemiology, and ultimately would allow to 
adapt public health prevention strategies. It is therefore crucial to evaluate the veracity of reservoir 
tolerance to hantaviruses and super-spreading events, to identify its genetic bases as well as its 
phenotypic plasticity. In particular, the role of co-infection has been emphasized to explain some cases 
of super-spreading see examples in [118]. How and which additional infections modulate the quantity 
of hantavirus particles excreted in the environment, and how reservoir immunogenetics might 
influence the probability of such co-infections through antagonistic pleiotropy (i.e., genetic trade-offs) 
are important questions to address in future research. 
4.3. Difficulties to Define What Is a Non-Reservoir Species for Hantaviruses 
The notion of non-reservoir species is difficult to define because the absence of evidence  
(i.e., detection of a virus) is not evidence in itself. 
Non-reservoir species may correspond to species that have never been exposed to the virus or 
species that have never been conceived as potential reservoirs (because of their taxonomic rank or 
because of the regions they inhabit). Until recently, hantaviruses were thought to be maintained in 
nature in rodent reservoirs from Eurasia and Americas solely. However, new hantavirus species have 
been described in African rodents e.g., Sangassou, [119] but also in small mammals other than rodents 
e.g., Talpidae, Soricidae, Chiroptera, see for a recent review [20]. Non-reservoir species may also be 
those that die extremely quickly upon infection hence limiting the probability of detecting positive 
individuals in wild populations. Finally, non-reservoir species may also concern those in which 
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hantavirus could not be able to enter and/or replicate within cells. In these two latter cases, no 
hantavirus would be detected and the term ―non-reservoir‖ would embrace species highly susceptible 
and highly resistant to the virus. 
A last but not least difficulty arises from the fact that different hantaviruses may produce opposite 
effects according to the host species considered. For example, Maporal virus (MAPV), a hantavirus 
that was originally isolated from an arboreal rice rat, Oecomys bicolor, causes disease in the Syrian 
golden hamster, Mesocricetus auratus, that is clinically and pathologically remarkably similar to 
HCPS [120]. Note that there is presently no evidence that MAPV is pathogenic in humans.  
After infection with ANDV, hamsters also develop HCPS-like disease that faithfully mimics the 
human condition with respect to incubation period and pathophysiology of disease. On the contrary, 
the closely related human pathogen SNV can replicate in hamsters but does not cause overt disease 
while Old World hantaviruses such as PUUV, HTNV, SEOV, and DOBV only produce subclinical 
infections [121]. Thus disease and infection outcomes do not seem to correlate in this animal model 
with human disease-causing potential. 
Until now, rodent models such as the golden hamster or the laboratory mouse are considered as 
useful ones to study the pathogenesis of hantavirus disease in humans and to assess the role of 
potential therapeutic agents. In parallel, it would be worth comparing immunology in reservoir and 
non-reservoir species for which rodent host/hantavirus interactions lead to radically different outcomes. 
It could help emphasizing mechanisms and genetic characteristics underlying such differences. In 
particular, unraveling the processes governing persistent infection and clearance of the virus in the 
natural hosts could open new avenues for human medical research. 
4.4. Differences in Hantavirus Virulence 
This review deliberately focused on rodent reservoir and human immunogenetics. Comparative 
genomics of hantaviruses is an obligatory counterpart to fully understand reservoir or human/hantavirus 
interactions and co-adaptation. Such approach coupling hantavirus sequencing from infected wild 
animals and humans could help to solve some of the unresolved questions concerning hantaviruses, 
including the determinants of pathogenicity or host switching, the receptor for entry into reservoir cells, etc. 
Genetically and antigenically closely related hantaviruses can show large differences in virulence. 
Recently a subdivision of the DBV into four closely related genotypes was proposed [119]—Dobrava, 
Sochi, Kurkino, and Saaremaa. These genotypes correspond to different phylogenetic lineages, and 
display specific host reservoirs, geographical distribution, and pathogenicity for suckling mice and 
humans. More detailed studies of these closely related hantavirus genotypes, causing either life-threatening 
(Dobrava, Sochi), relatively mild infection (Kurkino) or possibly only subclinical human infections 
(Saaremaa), could reveal the genetic determinants of virus-host interaction mechanisms leading  
to virulence. 
In addition, in vitro hantavirus infections of cultured cells (e.g., Vero E6, CHO, HUVECs) have 
suggested that non-pathogenic hantaviruses use β1 integrin as receptor for cell entry while the 
pathogenic ones use β3 integrin [123]. Hantaviruses carried by the Microtus-voles, such as Tula virus 
(TULV), or Sangassou, which is harbored by the African wood mouse, Hylomyscus simus, were 
demonstrated to infect humans, although this seems to be rare [124–126], but to use β1 integrin, at least 
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in cell culture models. This highlights the needs to better understand the receptors used by pathogenic 
or non-pathogenic hantaviruses and the potential links between these receptors and hantavirus 
pathogenicity in humans. Whether the newly found shrew-, mole- and bat-borne viruses infect other 
animals including humans, and if so with which consequences, also remains to be elucidated. By this 
way, hantavirus comparative genomics would help to reveal some of the genetic determinants of 
human pathogenicity. 
5. Concluding Remarks 
In summary, this review aimed at highlighting a number of important immunity-related genes that 
seem to be associated with the clinical course of hantaviral disease in humans, and the susceptibility of 
humans and rodents to hantaviruses. Beyond this list, we wanted to emphasize the necessity, in the 
very near future, to ―infect‖ the classical human immunogenetics approach both with evolutionary 
biology and with the datasets produced by the human genome projects. This combination of 
approaches, the future accumulation of genetic data using new generation sequencing technologies and 
genome-wide association studies, as well as closer collaborations between researches developed on wild 
reservoirs and humans, should ultimately improve our knowledge of hantavirus risk and epidemiology. 
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